The Motley Fool

Key Data Points

Primary metrics and data points about Gilead Sciences.
Current Price: $100.81
Prev Close: $100.27
Open: $100.03
Bid: $100.75
Ask: $100.87
Day's Range: $98.07 - $101.16
52wk Range: $85.95 - $123.37
Volume: 11,822,983
Avg Vol 12,744,626
Market Cap: $148B
P/E (ttm): 10.54
EPS (ttm): $9.51
Div & Yield: $1.72 (1.7%)

News and Headlines

Latest news about Gilead Sciences from

Business Summary

Industry, sector and description for Gilead Sciences.

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GILD vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Gilead Sciences.
CAPS Rating 5 out of 5
3387 Outperform
81 Underperform
CAPS All Stars
779 Outperform
13 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John C. Martin, CEO

83% Approve

Based on 137 Ratings

More Details for Gilead SciencesJobs

Powered by

More Details about Gilead Sciences

Primary metrics and data points about Gilead Sciences.

Company Photos

Powered by Working at